Large-scale testing (Phase 3)Study completedNCT01479868
What this trial is testing
Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1
Who this might be right for
Hepatitis C Virus Genotype-1
Janssen R&D Ireland 109